Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMC 2018-05-01
Serie:Experimental Hematology & Oncology
Ämnen:
Non-small cell lung cancer
Immune checkpoint inhibitor
Nivolumab
Pericardial effusion
Corticosteroids
Länkar:http://link.springer.com/article/10.1186/s40164-018-0104-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk